APA aipamena

Abdulrahim A. Alzain, P., Elbadwi, F. A., & Alsamani, F. O. (2022). Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies. Elsevier.

Chicago Style aipamena

Abdulrahim A. Alzain, PhD, Fatima A. Elbadwi, and Fatima O. Alsamani. Discovery of Novel TMPRSS2 Inhibitors for COVID-19 Using in Silico Fragment-based Drug Design, Molecular Docking, Molecular Dynamics, and Quantum Mechanics Studies. Elsevier, 2022.

MLA aipamena

Abdulrahim A. Alzain, PhD, et al. Discovery of Novel TMPRSS2 Inhibitors for COVID-19 Using in Silico Fragment-based Drug Design, Molecular Docking, Molecular Dynamics, and Quantum Mechanics Studies. Elsevier, 2022.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.